Loading…
Lobbying Spend
—
Filings
21
Firms Hired
1
Active Period
2018–2023
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, CCIA supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which CCIA has supported to achieve these goals. Additionally, CCIA supported the SHIP Act HR 8825. To note, CCIA submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. CCIA supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, CCIA noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. CCIA also supported the PREPARE Act (H.R. 7513). Finally, CCIA supports the Cannabidiol and Marijuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).
Client expense: — · Firm income: $8,000
Matched citations: HR 1996
CCIA supports the Secure and Fair Enforcement (SAFE) Banking Act (HR 1996). Cannabis businesses do not enjoy access to the same banking services enjoyed by every other legally operating business in the United States. The SAFE Banking Act would create a safe harbor for banks to service cannabis industry clients thus enabling cannabis businesses access to checking accounts, lines of credit and other standard business banking services. CCIA's support of SAFE Banking included its provision in the National Defense Authorization Act (NDAA) and America COMPETES bill, and other legislative vehicles including the end of year omnibus. CCIA also was active on the CLIMB Act HR. 8200, a bill that provides safe harbors for financial institutions, government programs, and capital markets.
Client expense: — · Firm income: $8,000
Matched citations: HR 1996
Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act
2022 · fourth_quarter · Firm: THE LIAISON GROUP, LLC
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, CCIA supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which CCIA has supported to achieve these goals. Additionally, CCIA supported the SHIP Act HR 8825. To note, CCIA submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. CCIA supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, CCIA noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. CCIA also supported the PREPARE Act (H.R. 7513). Finally, CCIA supports the Cannabidiol and Marijuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).
Client expense: — · Firm income: $8,000
Matched citations: HR 3105
Marijuana Opportunity Reinvestment and Expungement Act
2022 · fourth_quarter · Firm: THE LIAISON GROUP, LLC
Supported efforts to reform criminal justice policy and the different treatment on the federal and state level of individuals incarcerated for cannabis offenses including, the HOPE Act (H.R. 6129), the MORE Act (H.R. 3617) and the Cannabis Administration and Opportunity Act (S4591). CCIA has also supported comprehensive cannabis reform efforts as they develop in the Senate and the White House in conjunction with the Administration's announcement around cannabis pardons and a scheduling review.
Client expense: — · Firm income: $8,000
Matched citations: H.R. 3617
Philippine Human Rights Act
2022 · fourth_quarter · Firm: THE LIAISON GROUP, LLC
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, CCIA supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which CCIA has supported to achieve these goals. Additionally, CCIA supported the SHIP Act HR 8825. To note, CCIA submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. CCIA supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, CCIA noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. CCIA also supported the PREPARE Act (H.R. 7513). Finally, CCIA supports the Cannabidiol and Marijuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).
Client expense: — · Firm income: $8,000
Matched citations: HR 3884
Medical Marijuana Research Act
2022 · fourth_quarter · Firm: THE LIAISON GROUP, LLC
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, CCIA supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which CCIA has supported to achieve these goals. Additionally, CCIA supported the SHIP Act HR 8825. To note, CCIA submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. CCIA supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, CCIA noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. CCIA also supported the PREPARE Act (H.R. 7513). Finally, CCIA supports the Cannabidiol and Marijuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).
Client expense: — · Firm income: $8,000
Matched citations: HR 5657
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, CCIA supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which CCIA has supported to achieve these goals. Additionally, CCIA supported the SHIP Act HR 8825. To note, CCIA submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. CCIA supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, CCIA noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. CCIA also supported the PREPARE Act (H.R. 7513). Finally, CCIA supports the Cannabidiol and Marijuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).
Client expense: — · Firm income: $8,000
Matched citations: HR 5977
Harnessing Opportunities by Pursuing Expungement Act of 2021
2022 · fourth_quarter · Firm: THE LIAISON GROUP, LLC
Supported efforts to reform criminal justice policy and the different treatment on the federal and state level of individuals incarcerated for cannabis offenses including, the HOPE Act (H.R. 6129), the MORE Act (H.R. 3617) and the Cannabis Administration and Opportunity Act (S4591). CCIA has also supported comprehensive cannabis reform efforts as they develop in the Senate and the White House in conjunction with the Administration's announcement around cannabis pardons and a scheduling review.
Client expense: — · Firm income: $8,000
Matched citations: H.R. 6129
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, CCIA supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which CCIA has supported to achieve these goals. Additionally, CCIA supported the SHIP Act HR 8825. To note, CCIA submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. CCIA supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, CCIA noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. CCIA also supported the PREPARE Act (H.R. 7513). Finally, CCIA supports the Cannabidiol and Marijuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).
Client expense: — · Firm income: $8,000
Matched citations: H.R. 7513
CCIA supports the Secure and Fair Enforcement (SAFE) Banking Act (HR 1996). Cannabis businesses do not enjoy access to the same banking services enjoyed by every other legally operating business in the United States. The SAFE Banking Act would create a safe harbor for banks to service cannabis industry clients thus enabling cannabis businesses access to checking accounts, lines of credit and other standard business banking services. CCIA's support of SAFE Banking included its provision in the National Defense Authorization Act (NDAA) and America COMPETES bill, and other legislative vehicles including the end of year omnibus. CCIA also was active on the CLIMB Act HR. 8200, a bill that provides safe harbors for financial institutions, government programs, and capital markets.
Client expense: — · Firm income: $8,000
Matched citations: HR. 8200
Small and Homestead Independent Producers Act of 2022
2022 · fourth_quarter · Firm: THE LIAISON GROUP, LLC
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, CCIA supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which CCIA has supported to achieve these goals. Additionally, CCIA supported the SHIP Act HR 8825. To note, CCIA submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. CCIA supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, CCIA noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. CCIA also supported the PREPARE Act (H.R. 7513). Finally, CCIA supports the Cannabidiol and Marijuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).
Client expense: — · Firm income: $8,000
Matched citations: HR 8825
Cannabidiol and Marihuana Research Expansion Act
2022 · fourth_quarter · Firm: THE LIAISON GROUP, LLC
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, CCIA supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which CCIA has supported to achieve these goals. Additionally, CCIA supported the SHIP Act HR 8825. To note, CCIA submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. CCIA supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, CCIA noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. CCIA also supported the PREPARE Act (H.R. 7513). Finally, CCIA supports the Cannabidiol and Marijuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).
Client expense: — · Firm income: $8,000
Matched citations: S.253
Cannabis Administration and Opportunity Act
2022 · fourth_quarter · Firm: THE LIAISON GROUP, LLC
Supported efforts to reform criminal justice policy and the different treatment on the federal and state level of individuals incarcerated for cannabis offenses including, the HOPE Act (H.R. 6129), the MORE Act (H.R. 3617) and the Cannabis Administration and Opportunity Act (S4591). CCIA has also supported comprehensive cannabis reform efforts as they develop in the Senate and the White House in conjunction with the Administration's announcement around cannabis pardons and a scheduling review.
Client expense: — · Firm income: $8,000
Matched citations: S4591
CCIA supports the Secure and Fair Enforcement (SAFE) Banking Act (HR 1996). Cannabis businesses do not enjoy access to the same banking services enjoyed by every other legally operating business in the United States. The SAFE Banking Act would create a safe harbor for banks to service cannabis industry clients thus enabling cannabis businesses access to checking accounts, lines of credit and other standard business banking services. CCIA's support of SAFE Banking included its provision in the National Defense Authorization Act (NDAA) and America COMPETES bill, and other legislative vehicles. CCIA also was active on the CLIMB Act HR. 8200, a bill that provides safe harbors for financial institutions, government programs, and capital markets.
Client expense: — · Firm income: $8,000
Matched citations: HR 1996
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, CCIA supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which CCIA has supported to achieve these goals. Additionally, CCIA supported the SHIP Act HR 8825. To note, CCIA submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. CCIA supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, CCIA noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. CCIA also supported the PREPARE Act (H.R. 7513). Finally, CCIA supports the Cannabidiol and Marijuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).
Client expense: — · Firm income: $8,000
Matched citations: HR 1996
Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act
2022 · third_quarter · Firm: THE LIAISON GROUP, LLC
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, CCIA supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which CCIA has supported to achieve these goals. Additionally, CCIA supported the SHIP Act HR 8825. To note, CCIA submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. CCIA supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, CCIA noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. CCIA also supported the PREPARE Act (H.R. 7513). Finally, CCIA supports the Cannabidiol and Marijuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).
Client expense: — · Firm income: $8,000
Matched citations: HR 3105
Marijuana Opportunity Reinvestment and Expungement Act
2022 · third_quarter · Firm: THE LIAISON GROUP, LLC
Supported efforts to reform criminal justice policy and the different treatment on the federal and state level of individuals incarcerated for cannabis offenses including, the HOPE Act (H.R. 6129), the MORE Act (H.R. 3617) and the Cannabis Administration and Opportunity Act (S4591). CCIA has also supported comprehensive cannabis reform efforts as they develop in the Senate.
Client expense: — · Firm income: $8,000
Matched citations: H.R. 3617
Philippine Human Rights Act
2022 · third_quarter · Firm: THE LIAISON GROUP, LLC
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, CCIA supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which CCIA has supported to achieve these goals. Additionally, CCIA supported the SHIP Act HR 8825. To note, CCIA submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. CCIA supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, CCIA noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. CCIA also supported the PREPARE Act (H.R. 7513). Finally, CCIA supports the Cannabidiol and Marijuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).
Client expense: — · Firm income: $8,000
Matched citations: HR 3884
Medical Marijuana Research Act
2022 · third_quarter · Firm: THE LIAISON GROUP, LLC
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, CCIA supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which CCIA has supported to achieve these goals. Additionally, CCIA supported the SHIP Act HR 8825. To note, CCIA submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. CCIA supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, CCIA noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. CCIA also supported the PREPARE Act (H.R. 7513). Finally, CCIA supports the Cannabidiol and Marijuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).
Client expense: — · Firm income: $8,000
Matched citations: HR 5657
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, CCIA supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which CCIA has supported to achieve these goals. Additionally, CCIA supported the SHIP Act HR 8825. To note, CCIA submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. CCIA supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, CCIA noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. CCIA also supported the PREPARE Act (H.R. 7513). Finally, CCIA supports the Cannabidiol and Marijuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).
Client expense: — · Firm income: $8,000
Matched citations: HR 5977
Harnessing Opportunities by Pursuing Expungement Act of 2021
2022 · third_quarter · Firm: THE LIAISON GROUP, LLC
Supported efforts to reform criminal justice policy and the different treatment on the federal and state level of individuals incarcerated for cannabis offenses including, the HOPE Act (H.R. 6129), the MORE Act (H.R. 3617) and the Cannabis Administration and Opportunity Act (S4591). CCIA has also supported comprehensive cannabis reform efforts as they develop in the Senate.
Client expense: — · Firm income: $8,000
Matched citations: H.R. 6129
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, CCIA supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which CCIA has supported to achieve these goals. Additionally, CCIA supported the SHIP Act HR 8825. To note, CCIA submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. CCIA supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, CCIA noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. CCIA also supported the PREPARE Act (H.R. 7513). Finally, CCIA supports the Cannabidiol and Marijuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).
Client expense: — · Firm income: $8,000
Matched citations: H.R. 7513
CCIA supports the Secure and Fair Enforcement (SAFE) Banking Act (HR 1996). Cannabis businesses do not enjoy access to the same banking services enjoyed by every other legally operating business in the United States. The SAFE Banking Act would create a safe harbor for banks to service cannabis industry clients thus enabling cannabis businesses access to checking accounts, lines of credit and other standard business banking services. CCIA's support of SAFE Banking included its provision in the National Defense Authorization Act (NDAA) and America COMPETES bill, and other legislative vehicles. CCIA also was active on the CLIMB Act HR. 8200, a bill that provides safe harbors for financial institutions, government programs, and capital markets.
Client expense: — · Firm income: $8,000
Matched citations: HR. 8200
Small and Homestead Independent Producers Act of 2022
2022 · third_quarter · Firm: THE LIAISON GROUP, LLC
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, CCIA supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which CCIA has supported to achieve these goals. Additionally, CCIA supported the SHIP Act HR 8825. To note, CCIA submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. CCIA supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, CCIA noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. CCIA also supported the PREPARE Act (H.R. 7513). Finally, CCIA supports the Cannabidiol and Marijuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).
Client expense: — · Firm income: $8,000
Matched citations: HR 8825
Cannabidiol and Marihuana Research Expansion Act
2022 · third_quarter · Firm: THE LIAISON GROUP, LLC
As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, CCIA supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. HR 1996, HR 3884 and HR 3105 are the three primary pieces of legislation which CCIA has supported to achieve these goals. Additionally, CCIA supported the SHIP Act HR 8825. To note, CCIA submitted comments to the discussion draft of the Cannabis Administration and Opportunity Act (CAOA) introduced by Senators Schumer, Booker and Wyden last year. CCIA supports the Senators' comprehensive approach to reform and looks forward to working with legislators on another version of the bill when it is formally introduced. Additionally, CCIA noted the introduction of HR 5977 by Congresswoman Mace and the Hope Act by Reps. Ocasio-Cortez and Joyce during the fourth quarter of 2021 and looks forward to working with these congressional offices to advance areas of critical reform this year. CCIA also supported the PREPARE Act (H.R. 7513). Finally, CCIA supports the Cannabidiol and Marijuana Research Expansion Act (S.253) and the Medical Marijuana Research Act (HR 5657).
Client expense: — · Firm income: $8,000
Matched citations: S.253
Source: Senate LDA